Schedule 13G ownership disclosure

Arcutis Biotherapeutics Inc

Security class unavailable · CUSIP: 03969K108

Event date: 2024-02-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
12,128,533
Percent of class
10.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000053417-24-000050
Form type
SC 13G/A
Filer
Arcutis Biotherapeutics, Inc.
CIK
CIK 1787306
Filed
Mar 06, 2024
Reporting period
Feb 29, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub